Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-06-11

Clinical Trial Update: Sulodexide Treatment in Patients With Dense Deposit Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial of sulodexide for Dense Deposit Disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulodexide (sulodexide)

Snippet

Sponsor: University of Iowa | Conditions: Dense Deposit Disease | Phase 1 | Status: WITHDRAWN